King Luther Capital Management Corp Boosts Holdings in HealthEquity, Inc. $HQY

King Luther Capital Management Corp lifted its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 60.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 80,584 shares of the company’s stock after buying an additional 30,394 shares during the period. King Luther Capital Management Corp’s holdings in HealthEquity were worth $7,637,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors have also recently added to or reduced their stakes in the business. Sivia Capital Partners LLC acquired a new stake in HealthEquity during the second quarter worth $306,000. Stephens Inc. AR increased its position in shares of HealthEquity by 20.2% during the 2nd quarter. Stephens Inc. AR now owns 6,422 shares of the company’s stock worth $673,000 after purchasing an additional 1,079 shares during the last quarter. Cullen Frost Bankers Inc. increased its position in shares of HealthEquity by 172.3% during the 2nd quarter. Cullen Frost Bankers Inc. now owns 354 shares of the company’s stock worth $37,000 after purchasing an additional 224 shares during the last quarter. Ethic Inc. raised its holdings in HealthEquity by 36.2% in the 2nd quarter. Ethic Inc. now owns 6,870 shares of the company’s stock valued at $721,000 after buying an additional 1,826 shares during the period. Finally, Caitong International Asset Management Co. Ltd acquired a new position in HealthEquity in the second quarter valued at about $33,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at HealthEquity

In other news, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the transaction, the executive vice president directly owned 73,979 shares of the company’s stock, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Elimelech Rosner sold 10,959 shares of the firm’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the sale, the executive vice president directly owned 45,742 shares in the company, valued at $4,366,073.90. This trade represents a 19.33% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 1.50% of the company’s stock.

HealthEquity Price Performance

HQY stock opened at $78.88 on Friday. The business’s 50-day moving average is $86.91 and its two-hundred day moving average is $91.75. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. The firm has a market capitalization of $6.74 billion, a P/E ratio of 36.18, a P/E/G ratio of 0.96 and a beta of 0.24. HealthEquity, Inc. has a 1 year low of $72.76 and a 1 year high of $116.65.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Wednesday, December 3rd. The company reported $1.01 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.11. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The firm had revenue of $322.16 million for the quarter, compared to analysts’ expectations of $320.92 million. During the same quarter last year, the company earned $0.78 earnings per share. The firm’s revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

HQY has been the topic of a number of research analyst reports. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a research note on Monday, January 19th. Raymond James Financial set a $100.00 price target on HealthEquity in a research note on Tuesday. The Goldman Sachs Group cut HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 price objective for the company. in a research note on Friday, January 9th. BTIG Research decreased their target price on HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a research note on Tuesday. Finally, BMO Capital Markets reaffirmed a “market perform” rating on shares of HealthEquity in a research report on Thursday, December 4th. One research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, HealthEquity currently has an average rating of “Moderate Buy” and a consensus target price of $113.87.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.